Totowa, N.J.-based Vital Signs pulls in about $250 million in annual sales of devices for respiratory care, anesthesiology and patient monitoring. The company has more than 1,000 workers and a manufacturing operation in Shenzhen, China, according to a press release.
“The acquisition of Vital Signs doubles the size of our specialty disposables business and transforms it into an industry leader by adding global scale and a new call point in anesthesia. We are in a better position to serve customers in this large, global and growing market with a broader product portfolio and complementary expertise in respiratory and anesthesia care,” CareFusion chairman & CEO Kieran Gallahue said in prepared remarks.
The deal was originally announced in mid-November. San Diego-based CareFusion put $100 million on a 40% stake in Israel-based Caesarea Medical Electronics in early December.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.